Cleaved caspase-3 and Ki67 have recently been proposed as short-term pharmacodynamic biomarkers for the combination of ONC201, temozolomide, and radiation based on in vivo studies using an orthotopic GBM mouse model [131]. The gene discussed is CASP3; the disease is glioblastoma.